An inspection of the GeneCards database revealed IPO5 to be highly expressed in the NT2/D1 embryonic carcinoma cell line; this provides an additional point of interest, as IPO5 is transiently upregulated in differentiating embryonic stem cells [47] and may therefore be involved in the transition between developmental fates. This evidence concerns the gene IPO5 and embryonal carcinoma.